Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors

NCT04917744 · clinicaltrials.gov ↗

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Carcinoma

Interventions

PROCEDURE: Biospecimen Collection
OTHER: Laboratory Biomarker Analysis
OTHER: Medical Chart Review

Sponsor

Mayo Clinic